Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions

Clinical trial NCT06316336 · UNKNOWN

Trial details

NCT number: NCT06316336
Sponsor: Pharma Nueva
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Vollunteer

Start date: 2024-06-10
Primary completion: 2024-06-22
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.